Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Hairui Pharmaceutical is a prominent subsidiary of the Yangzijiang Pharmaceutical Group, based in Guangzhou, China. Founded in 2004, the company operates as a comprehensive pharmaceutical entity focusing on the research, development, manufacturing, and commercialization of high-quality chemical drugs. Its therapeutic focus includes cardiovascular health, gastroenterology, and anti-infective treatments, with a robust portfolio of oral solid dosage forms. The company's state-of-the-art manufacturing facilities are GMP-certified, supporting both domestic supply and the group's international expansion strategy. As a key regional hub for its parent group, Hairui Pharmaceutical integrates advanced technology with large-scale production to address diverse medical needs. The facility is located in the Guangzhou Science City and serves as a major high-tech enterprise in the Guangdong province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzijiang Pharmaceutical Group Guangzhou Hairui Pharmaceutical.